학술논문
Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double-blind, multicenter controlled trial
Document Type
Artikel
Author
Source
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 12(11):3021-3030
Subject
Language
English
English
English
ISSN
1600-6143